| 摘要 |
The present invention relates to imidazo[1,2-b][1,2,4]triazines which are 2-fluoro-N-[(2R)-2-hydroxypropyl]-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide or 2-chloro-N-[(1S)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide; or to pharmaceutically acceptable salts of any of the above stated compounds, that are inhibitors of c-Met and are useful in the treatment of c-Met associated diseases including cancer. |
